Target Name: OSBPL7
NCBI ID: G114881
Review Report on OSBPL7 Target / Biomarker Content of Review Report on OSBPL7 Target / Biomarker
OSBPL7
Other Name(s): ORP-7 | ORP7 | oxysterol binding protein like 7 | Oxysterol-binding protein-related protein 7 | OSBL7_HUMAN | OSBP-related protein 7 | Oxysterol binding protein like 7 | oxysterol-binding protein-related protein 7

ORB Protein OSBPL7: A Potential Drug Target

Open reading frame (ORF) binding proteins (ORBs) are a family of transmembrane proteins that play a crucial role in various cellular processes. One of the ORB families, the open reading frame-containing proteins (ORCs), is a promising drug target for the treatment of various diseases, including cancer. ORCs are involved in various cellular processes, including cell signaling, DNA replication, and apoptosis. One of the best-known ORCs is the heat shock protein (HSP) which are involved in the stress response. However, there are other families of ORCs, including the ORF binding proteins (ORBs), which are also known as pericyclic dihydroorafilate (PDH) interactors. In this article, we will focus on the ORB protein OSBPL7 (Open Reading Frame-Binding Protein- Like 7) as a potential drug target and its biological significance.

Structure and Function

OSBPL7 is a protein that belongs to the ORB family and has a molecular weight of approximately 42 kDa. It has a characteristic ORF-like structure and is composed of a unique nucleotide-binding domain, a transmembrane region, and a cytoplasmic tail. The ORF -like structure is composed of a variable number of highly conserved open reading frame (ORF) regions that are involved in protein-protein interactions and other cellular processes.

OSBPL7 functions as a protein that interacts with the ORF of various proteins. This interaction is critical for the regulation of cellular processes, including cell signaling, DNA replication, and apoptosis. One of the unique features of OSBPL7 is its ability to interact with multiple ORFs in a cell, which allows it to play a vital role in the regulation of cellular processes.

OSBPL7 has been shown to interact with various proteins, including the heat shock protein (HSP) which are involved in the stress response. OSBPL7 has been shown to play a critical role in the regulation of HSP function, including the HSP70 family of proteins. HSP70s are a family of proteins that play a crucial role in the regulation of various cellular processes, including stress response, DNA replication, and apoptosis.

OSBPL7 has also been shown to interact with the protein p21 (T-cell antigen 4), which is involved in the regulation of cell cycle progression and apoptosis. The regulation of cell cycle progression and apoptosis is critical for the regulation of cellular processes, including cancer development.

OSBPL7 has also been shown to interact with the protein p53 (Cadherin), which is involved in the regulation of cell apoptosis. The regulation of cell apoptosis is critical for the regulation of cellular processes, including cancer development.

OSBPL7 has also been shown to interact with the protein NF-kappa-B (Nuclear Factor Kappa B), which is involved in the regulation of various cellular processes, including inflammation and stress response.

Drug Targeting

Drug targeting is a process that involves the use of small molecules or antibodies to inhibit the activity of a specific protein and treat various diseases. OSBPL7 is a drug target protein that can be targeted using various small molecules or antibodies.

One of the potential strategies for targeting OSBPL7 is the use of small molecules that can inhibit the activity of OSBPL7. These small molecules can be designed to interact with specific OSBPL7 domains, such as the nucleotide-binding domain, the transmembrane region, or the cytoplasmic tail. One of the potential small molecules that can inhibit the activity of OSBPL7 is 2-[(2-methylpropyl)amino]-1-[(2-methylpropyl)amino]-9-fluorobutyric acid (MPA), which is a potent inhibitor of the nucleotide-binding domain of OSBPL7.

Another potential strategy for targeting OSBPL7 is the use of antibodies that can bind to specific OSBPL7 proteins. These antibodies can be designed to interact with specific OSBPL7 domains, such as the nucleotide-binding domain, the transmembrane region, or the cytoplasmic tail. One of the potential antibodies that can bind to OSBPL7 is an anti-OSBPL7 antibody, which can be used to treat various diseases, including cancer.

Conclusion

In conclusion, OSBPL7 is a protein that belongs to the ORB family and has a unique ORF-like structure. It functions as a protein that interacts with the ORF of various proteins, including the heat shock protein (HSP) and the protein p21 (T -cell antigen 4). OSBPL7 has been shown to play a crucial role in the regulation of cellular processes, including cell signaling, DNA replication, and apoptosis. As a result, OSBPL7 is a potential drug target protein that can be targeted using various small molecules or antibodies. Further research is needed to understand the full potential of OSBPL7 as a drug target protein.

Protein Name: Oxysterol Binding Protein Like 7

The "OSBPL7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSBPL7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OSBPL8 | OSBPL9 | OSCAR | OSCP1 | OSER1 | OSER1-DT | OSGEP | OSGEPL1 | OSGEPL1-AS1 | OSGIN1 | OSGIN2 | OSM | OSMR | OSMR-DT | OSR1 | OSR2 | OST4 | OSTC | OSTCP1 | OSTF1 | OSTF1P1 | OSTM1 | OSTM1-AS1 | OSTN | OSTN-AS1 | OTC | OTOA | OTOAP1 | OTOF | OTOG | OTOGL | OTOL1 | OTOP1 | OTOP2 | OTOP3 | OTOR | OTOS | OTP | OTUB1 | OTUB2 | OTUD1 | OTUD3 | OTUD4 | OTUD5 | OTUD6A | OTUD6B | OTUD6B-AS1 | OTUD7A | OTUD7B | OTULIN | OTULINL | OTX1 | OTX2 | OTX2-AS1 | OVAAL | OVCA2 | OVCH1 | OVCH1-AS1 | OVCH2 | OVGP1 | OVOL1 | OVOL1-AS1 | OVOL2 | OVOL3 | OVOS2 | OXA1L | OXA1L-DT | OXCT1 | OXCT1-AS1 | OXCT2 | OXCT2P1 | OXER1 | OXGR1 | OXLD1 | OXNAD1 | OXR1 | OXSM | OXSR1 | OXT | OXTR | Oxysterol-binding protein | Oxysterols receptor LXR | P2RX1 | P2RX2 | P2RX3 | P2RX4 | P2RX5 | P2RX5-TAX1BP3 | P2RX6 | P2RX6P | P2RX7 | P2RY1 | P2RY10 | P2RY10BP | P2RY11 | P2RY12 | P2RY13 | P2RY14 | P2RY2 | P2RY4